Simulations Plus (SLP) Reports Q3 EPS of $0.11

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. AVGO
2. JBLU
3. CDNS
4. META
5. SSD
6. ANT
7. PECO
8. AGYS
9. HWKN
10. INTC

Go back to Simulations Plus (SLP) Reports Q3 EPS of $0.11

Simulations Plus Reports Third Quarter FY2016 Financial Results

July 14, 2016 4:01 PM EDT

Record quarterly revenue, 9moFY16 diluted EPS increased 23% to a record $0.242 from $0.196

LANCASTER, Calif.--(BUSINESS WIRE)-- Simulations Plus, Inc. (NASDAQ: SLP), the premier provider of simulation and modeling software and consulting services for pharmaceutical discovery and development from the earliest discovery through all phases of clinical trials, today reported financial results for its third quarter of fiscal year 2016 (3QFY16) and the first nine months of fiscal year 2016 (9moFY16), the period ended May 31, 2016.

3QFY16 highlights compared with 3QFY15:

Net revenues increased 1.2% to $6.01 million, an increase of $70,000 from $5.94 million... More